Clinical Trials Browser

Breast Neoplasms × HM781-36B × Clear all

NCT02659514 2022-03-11

Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer

Phase 2 Completed

67 enrolled 16 charts

Breast Neoplasms

NCT02418689 2022-01-20

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

Phase 2 Completed

Breast Neoplasms